Novel Non-Invasive Index for Prediction of Responders in Cardiac Resynchronization Therapy Using High-Resolution Magnetocardiography.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 11 2020
Historique:
pubmed: 10 11 2020
medline: 15 12 2021
entrez: 9 11 2020
Statut: ppublish

Résumé

Approximately one-third of patients with advanced heart failure (HF) do not respond to cardiac resynchronization therapy (CRT). We investigated whether the left ventricular (LV) conduction pattern on magnetocardiography (MCG) can predict CRT responders.Methods and Results:This retrospective study enrolled 56 patients with advanced HF (mean [±SD] LV ejection fraction [LVEF] 23±8%; QRS duration 145±19 ms) and MCG recorded before CRT. MCG-QRS current arrow maps were classified as multidirectional (MDC; n=28) or unidirectional (UDC; n=28) conduction based on a change of either ≥35° or <35°, respectively, in the direction of the maximal current arrow after the QRS peak. Baseline New York Heart Association functional class and LVEF were comparable between the 2 groups, but QRS duration was longer and the presence of complete left bundle branch block and LV dyssynchrony was higher in the UDC than MDC group. Six months after CRT, 30 patients were defined as responders, with significantly more in the UDC than MDC group (89% vs. 14%, respectively; P<0.001). Over a 5-year follow-up, Kaplan-Meyer analysis showed that adverse cardiac events (death or implantation of an LV assist device) were less frequently observed in the UDC than MDC group (6/28 vs. 15/28, respectively; P=0.027). Multivariate analysis revealed that UDC on MCG was the most significant predictor of CRT response (odds ratio 69.8; 95% confidence interval 13.14-669.32; P<0.001). Preoperative non-invasive MCG may predict the CRT response and long-term outcome after CRT.

Sections du résumé

BACKGROUND
Approximately one-third of patients with advanced heart failure (HF) do not respond to cardiac resynchronization therapy (CRT). We investigated whether the left ventricular (LV) conduction pattern on magnetocardiography (MCG) can predict CRT responders.Methods and Results:This retrospective study enrolled 56 patients with advanced HF (mean [±SD] LV ejection fraction [LVEF] 23±8%; QRS duration 145±19 ms) and MCG recorded before CRT. MCG-QRS current arrow maps were classified as multidirectional (MDC; n=28) or unidirectional (UDC; n=28) conduction based on a change of either ≥35° or <35°, respectively, in the direction of the maximal current arrow after the QRS peak. Baseline New York Heart Association functional class and LVEF were comparable between the 2 groups, but QRS duration was longer and the presence of complete left bundle branch block and LV dyssynchrony was higher in the UDC than MDC group. Six months after CRT, 30 patients were defined as responders, with significantly more in the UDC than MDC group (89% vs. 14%, respectively; P<0.001). Over a 5-year follow-up, Kaplan-Meyer analysis showed that adverse cardiac events (death or implantation of an LV assist device) were less frequently observed in the UDC than MDC group (6/28 vs. 15/28, respectively; P=0.027). Multivariate analysis revealed that UDC on MCG was the most significant predictor of CRT response (odds ratio 69.8; 95% confidence interval 13.14-669.32; P<0.001).
CONCLUSIONS
Preoperative non-invasive MCG may predict the CRT response and long-term outcome after CRT.

Identifiants

pubmed: 33162489
doi: 10.1253/circj.CJ-20-0325
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2166-2174

Auteurs

Takahiro Nakashima (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Shunsuke Usami (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Takeshi Aiba (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Shogo Oishi (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Yoshitaka Kimura (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Shoji Kawakami (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Yuko Yamada-Inoue (Y)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Soshiro Ogata (S)

Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center.

Nobuhiko Ueda (N)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Kenzaburo Nakajima (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Tsukasa Kamakura (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Mitsuru Wada (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Kenichiro Yamagata (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Kohei Ishibashi (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Koji Miyamoto (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Takashi Noda (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Satoshi Nagase (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Hideaki Kanzaki (H)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Chisato Izumi (C)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Satoshi Yasuda (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Shiro Kamakura (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Hiroshi Takaki (H)

Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center.

Masaru Sugimachi (M)

Department of Cardiovascular Dynamics, National Cerebral and Cardiovascular Center.

Kengo Kusano (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH